Aktis Oncology, Inc. (AKTS)

SEC filing

Aktis Oncology, Inc.

AKTS · CIK 2035832

4 · Sep 24, 2026 · Chief Medical Officer Czibere Akos sold 12.50K shares at $20.69/share ($258.6K); exercised options for 25K shares

Chief Medical Officer Czibere Akos sold 12.50K shares at $20.69/share ($258.6K); exercised options for 25K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).